MAIA Biotechnology, Inc.·4

Nov 4, 4:39 PM ET

Luput Cristian 4

4 · MAIA Biotechnology, Inc. · Filed Nov 4, 2024

Insider Transaction Report

Form 4
Period: 2024-11-01
Transactions
  • Purchase

    Common Stock

    2024-11-01$2.51/sh+22,133$55,554389,483 total
  • Purchase

    Warrants

    2024-11-01$2.26/sh+22,133$49,99822,133 total
    Exercise: $2.26From: 2025-05-01Exp: 2030-05-01Common Stock (22,133 underlying)
Footnotes (2)
  • [F1]The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on November 1, 2024.
  • [F2]These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options issued under the Issuer's 2021 Equity Incentive Plan on November 1, 2024. The options are exercisable beginning on the six month anniversary of the issuance date and expire 5-years after the initial exercise date.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT